Showing results (61-70 of 127) with videos related to
Sort By:
Pageof 13
Cancer|September 8, 2007
Weekly docetaxel versus docetaxel/gemcitabine in the treatment of elderly or poor performance status patients with advanced nonsmall cell lung cancer: a randomized phase 3 trial of the Minnie Pearl Cancer Research NetworkJohn D Hainsworth, David R Spigel, Cindy Farley, et al.Investigational New Drugs|May 15, 2002
Phase I study of JM-216 (an oral platinum analogue) in combination with paclitaxel in patients with advanced malignanciesSuzanne Jones, John Hainsworth, Howard A Burris, et al.Cancer|March 9, 2010
Oxaliplatin and capecitabine in the treatment of patients with recurrent or refractory carcinoma of unknown primary site: a phase 2 trial of the Sarah Cannon Oncology Research ConsortiumJohn D Hainsworth, David R Spigel, Howard A Burris, et al.Clinical Breast Cancer|March 21, 2009
Phase II trial of weekly docetaxel, vinorelbine, and trastuzumab in the first-line treatment of patients with HER2-positive metastatic breast cancerJeffrey R Infante, Denise A Yardley, Howard A Burris, et al.Cancer Investigation|March 10, 2010
Phase II study of capecitabine in combination with thalidomide in patients with metastatic breast cancerHoward A Burris, Suzanne F Jones, Dianna Shipley, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 11, 2009
Tracheoesophageal fistula formation in patients with lung cancer treated with chemoradiation and bevacizumabDavid R Spigel, John D Hainsworth, Denise A Yardley, et al.The Oncologist|December 8, 2009
Paclitaxel/carboplatin plus bevacizumab/erlotinib in the first-line treatment of patients with carcinoma of unknown primary siteJohn D Hainsworth, David R Spigel, Dana S Thompson, et al.European Journal of Cancer (Oxford, England : 1990)|May 3, 2025
Molecularly directed therapy in cancers of unknown primary: A systematic review and meta-analysisChris Labaki, Marc Eid, Ziad Bakouny, et al.Cancer Investigation|April 28, 2012
Phase 1 results from a study of romidepsin in combination with gemcitabine in patients with advanced solid tumorsSuzanne F Jones, Jeffrey R Infante, David R Spigel, et al.Cancer|February 17, 2018
Randomized phase 2 trial of pemetrexed, pemetrexed/bevacizumab, and pemetrexed/carboplatin/bevacizumab in patients with stage IIIB/IV non-small cell lung cancer and an Eastern Cooperative Oncology Group performance status of 2David R Spigel, John D Hainsworth, Mathew J Joseph, et al.Pageof 13